These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1629388)

  • 1. Use of drug combinations in treatment of opioid withdrawal.
    Stine SM; Kosten TR
    J Clin Psychopharmacol; 1992 Jun; 12(3):203-9. PubMed ID: 1629388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.
    Kleber HD; Topazian M; Gaspari J; Riordan CE; Kosten T
    Am J Drug Alcohol Abuse; 1987; 13(1-2):1-17. PubMed ID: 3687878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current pharmacotherapies for opioid dependence.
    Kosten TR
    Psychopharmacol Bull; 1990; 26(1):69-74. PubMed ID: 2196628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The place of detoxification in treatment of opioid dependence.
    Gowing LR; Ali RL
    Curr Opin Psychiatry; 2006 May; 19(3):266-70. PubMed ID: 16612211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    Gold MS
    Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T; Greenwald MK; Johnson RE; Liebson IA; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of clonidine in detoxification from opiates.
    Kleber HD; Gold MS; Riordan CE
    Bull Narc; 1980; 32(2):1-10. PubMed ID: 6907020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].
    Oliveros SC; Caballero L; Iruela LM
    Med Clin (Barc); 1990 Nov; 95(16):627-9. PubMed ID: 2097456
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of opioid withdrawal].
    Cortese S; Risso M
    Vertex; 2008; 19(77):522-6. PubMed ID: 18443666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive opioid receptor activation: a prerequisite mechanism involved in acute opioid withdrawal.
    Freye E; Levy J
    Addict Biol; 2005 Jun; 10(2):131-7. PubMed ID: 16191664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
    Carreño JE; Bobes J; Brewer C; Alvarez CE; San Narciso GI; Bascarán MT; Sánchez del Río J
    Addict Biol; 2002 Apr; 7(2):243-50. PubMed ID: 12006220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opioids: abuse liability and treatments for dependence.
    Ternes JW; O'Brien CP
    Adv Alcohol Subst Abuse; 1990; 9(1-2):27-45. PubMed ID: 2198785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
    Correia CJ; Walsh SL; Bigelow GE; Strain EC
    Psychopharmacology (Berl); 2006 Dec; 189(3):297-306. PubMed ID: 17013637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Narcotic withdrawal syndrome. Therapeutic methods].
    Cerdeño Impuesto V
    Rev Clin Esp; 1982 Oct; 167(1):65-9. PubMed ID: 6129686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.